Evidence map›Paper›PMID 25060372›Full record

Trial reportJournal of the American College of Cardiology2014

Management practices and major infections after cardiac surgery.

Annetine C Gelijns, Alan J Moskowitz, Michael A Acker, Michael Argenziano, Nancy L Geller, John D Puskas, Louis P Perrault, Peter K Smith, Irving L Kron, Robert E Michler and 17 more

2 registry-linked trialsAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Journal of the American College of Cardiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 67 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed, 2 pooled it
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01089712 completednot on this map

Management Practices and the Risk of Infection Following Cardiac Surgery

TypeobservationalSponsorIcahn School of Medicine at Mount SinaiRan2010 to 2013Enrolled5,158ConditionsCardiac Surgery, Infection, Postoperative Wound, Postoperative Wound Infection, Infections, Nosocomial
NCT04788082 nawithdrawnnot on this mapstarted 2017, after this paper: background citation

Clinical Impact of Rapid Prototyping 3D Models of Congenital Heart Disease on Surgical Management

TypeinterventionalSponsorChildren's National Research InstituteRan2017 to 2021Enrolled0ConditionsDouble Outlet Right Ventricle, Transposition of the Great Arteries, Truncus Arteriosus, Congenitally Corrected Transposition of the Great ArteriesArms3D Printed Heart Model
3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 2 syntheses or guidelines pooled it, 180 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Trends and Impact ofGastroenterology research · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Article
  19. Article
  20. Review

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors at 15 institutions in 2 countries.

Annetine C GelijnsInternational Center for Health Outcomes and Innovation Research (InCHOIR) in the Department of Health Evidence and Policy, Ichan School of Medicine at Mount Sinai, New York, New York. Electronic address: annetine.gelijns@mssm.edu.
Alan J MoskowitzInternational Center for Health Outcomes and Innovation Research (InCHOIR) in the Department of Health Evidence and Policy, Ichan School of Medicine at Mount Sinai, New York, New York.
Michael A AckerDepartment of Surgery, Division of Cardiovascular Surgery, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania.
Michael ArgenzianoDivision of Cardiothoracic Surgery, Department of Surgery, College of Physicians and Surgeons, Columbia University, New York, New York.
Nancy L GellerOffice of Biostatistics Research, National Heart, Lung, and Blood Institute, Bethesda, Maryland.
John D PuskasClinical Research Unit, Division of Cardiothoracic Surgery, Emory University School of Medicine, Atlanta, Georgia.
Louis P PerraultMontréal Heart Institute, University of Montréal, Montréal, Québec, Canada.
Peter K SmithDivision of Cardiovascular and Thoracic Surgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina.
Irving L KronDivision of Thoracic and Cardiovascular Surgery, University of Virginia School of Medicine, Charlottesville, Virginia.
Robert E MichlerDepartment of Cardiothoracic Surgery, Montefiore Medical Center/Albert Einstein College of Medicine, New York, New York.
Marissa A MillerDivision of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Bethesda, Maryland.
Timothy J GardnerCenter for Heart & Vascular Health, Christiana Care Health System, Newark, Delaware.
Deborah D AscheimInternational Center for Health Outcomes and Innovation Research (InCHOIR) in the Department of Health Evidence and Policy, Ichan School of Medicine at Mount Sinai, New York, New York.
Gorav AilawadiDivision of Thoracic and Cardiovascular Surgery, University of Virginia School of Medicine, Charlottesville, Virginia.
Pamela LacknerDepartment of Thoracic and Cardiovascular Surgery, Cleveland Clinic Foundation, Cleveland, Ohio.
Lyn A GoldsmithDivision of Cardiothoracic Surgery, Department of Surgery, College of Physicians and Surgeons, Columbia University, New York, New York.
Sophie RobichaudMontréal Heart Institute, University of Montréal, Montréal, Québec, Canada.
Rachel A MillerDepartment of Medicine, Division of Infectious Diseases, University of Iowa Carver College of Medicine, Iowa City, Iowa.
Eric A RoseInternational Center for Health Outcomes and Innovation Research (InCHOIR) in the Department of Health Evidence and Policy, Ichan School of Medicine at Mount Sinai, New York, New York.
T Bruce FergusonDepartment of Cardiovascular Sciences; East Carolina Heart Institute at East Carolina University, Greenville, North Carolina.
Keith A HorvathNIH Heart Center at Suburban Hospital, Bethesda, Maryland.
Ellen G MoqueteInternational Center for Health Outcomes and Innovation Research (InCHOIR) in the Department of Health Evidence and Policy, Ichan School of Medicine at Mount Sinai, New York, New York.
Michael K ParidesInternational Center for Health Outcomes and Innovation Research (InCHOIR) in the Department of Health Evidence and Policy, Ichan School of Medicine at Mount Sinai, New York, New York.
Emilia BagiellaInternational Center for Health Outcomes and Innovation Research (InCHOIR) in the Department of Health Evidence and Policy, Ichan School of Medicine at Mount Sinai, New York, New York.
Patrick T O'GaraCardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts.
Eugene H BlackstoneDepartment of Thoracic and Cardiovascular Surgery, Cleveland Clinic Foundation, Cleveland, Ohio.
Cardiothoracic Surgical Trials Network (CTSN)
Icahn School of Medicine at Mount Sinai · USCleveland Clinic · USColumbia University · USMontreal Heart Institute · CANational Institutes of Health · USUniversity of Virginia · USAlbert Einstein College of Medicine · USBrigham and Women's Hospital · USCalifornia University of Pennsylvania · USChristiana Care Health System · USDuke University · USEast Carolina University · USEmory University · USSuburban Hospital · USUniversity of Iowa · US

Funding

REVISED CAROL ACT IIU01HL088942 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GELIJNS, ANNE CHRISTINE, MOSKOWITZ, ALAN J · 2007 to 2025
$122.6M
Clinical and Translational Science Collaborative of ClevelandUL1TR000439 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI KONSTAN, MICHAEL W. · 2012 to 2016
$50.0M
Network for Cardiothoracic Surgical Investigations in Cardiovascular MedicineUM1HL088925 · NHLBI · UNIVERSITY OF VIRGINIA · PI BADHWAR, VINAY, KRON, IRVING L. · 2013 to 2025
$6.8M
Cleveland Clinic Cardiothoracic Collaborative Clinical Center (C6)UM1HL088955 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI GILLINOV, ALAN MARC, PARRINO, PATRICK E · 2013 to 2025
$6.6M
Core Clinical Centers for the CTSNUM1HL088953 · NHLBI · DUKE UNIVERSITY · PI SMITH, PETER K · 2013 to 2017
$2.5M
Mitral Regurgitation, Heart Failure and Coronary Disease: Benefits to MV RepairUM1HL088939 · NHLBI · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI MICHLER, ROBERT E. · 2013 to 2016
$1.5M
CIHRNCATS NIH HHS UL1 TR000439NHLBI NIH HHS 7U01 HL088942NHLBI NIH HHS U01 HL088942NHLBI NIH HHS UM1 HL088925NHLBI NIH HHS UM1 HL088939NHLBI NIH HHS UM1 HL088953NHLBI NIH HHS UM1 HL088955
6 · The paper itself

Abstract

backgroundInfections are the most common noncardiac complication after cardiac surgery, but their incidence across a broad range of operations, as well as the management factors that shape infection risk, remain unknown.

objectivesThis study sought to prospectively examine the frequency of post-operative infections and associated mortality, and modifiable management practices predictive of infections within 65 days from cardiac surgery.

methodsThis study enrolled 5,158 patients and analyzed independently adjudicated infections using a competing risk model (with death as the competing event).

resultsNearly 5% of patients experienced major infections. Baseline characteristics associated with increased infection risk included chronic lung disease (hazard ratio [HR]: 1.66; 95% confidence interval [CI]: 1.21 to 2.26), heart failure (HR: 1.47; 95% CI: 1.11 to 1.95), and longer surgery (HR: 1.31; 95% CI: 1.21 to 1.41). Practices associated with reduced infection risk included prophylaxis with second-generation cephalosporins (HR: 0.70; 95% CI: 0.52 to 0.94), whereas post-operative antibiotic duration >48 h (HR: 1.92; 95% CI: 1.28 to 2.88), stress hyperglycemia (HR: 1.32; 95% CI: 1.01 to 1.73); intubation time of 24 to 48 h (HR: 1.49; 95% CI: 1.04 to 2.14); and ventilation >48 h (HR: 2.45; 95% CI: 1.66 to 3.63) were associated with increased risk. HRs for infection were similar with either <24 h or <48 h of antibiotic prophylaxis. There was a significant but differential effect of transfusion by surgery type (excluding left ventricular assist device procedures/transplant) (HR: 1.13; 95% CI: 1.07 to 1.20). Major infections substantially increased mortality (HR: 10.02; 95% CI: 6.12 to 16.39).

conclusionsMajor infections dramatically affect survival and readmissions. Second-generation cephalosporins were strongly associated with reduced major infection risk, but optimal duration of antibiotic prophylaxis requires further study. Given practice variations, considerable opportunities exist for improving outcomes and preventing readmissions. (Management Practices and Risk of Infection Following Cardiac Surgery; NCT01089712).

Indexed as

Disease ManagementAgedAnti-Bacterial AgentsAntibiotic ProphylaxisCardiac Surgical ProceduresConfidence IntervalsFemaleFollow-Up StudiesHumansIncidenceMaleMiddle AgedRetrospective StudiesRisk FactorsSurgical Wound InfectionTreatment OutcomeAnti-Bacterial Agentscardiac surgeryinfectionrisk factors

Identifiers

PMID25060372
PMCPMC4222509
OpenAlexW2062694978

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.